# MaxLinear share price today (MaxLinear, Inc., MXL)

> MaxLinear, Inc.'s results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 20% of past readings. MXL · Technology · Semiconductors · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/mxl

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $63.97 (+322.2% in a year)
- P/E: 22.3× (lower than 80% of the last 1 year)
- Revenue (Sep 2026): $218 M (+72.4% on a year ago)
- Profit (Sep 2026): $28.9 M
- Operating margin: 14.0% (+37.7 points on a year ago)
- ROE: −30%, FY25
- ROIC: −0.9%, against a 25.5% cost of capital: −26.4 points
- Profit that came in as cash: 333%, last 2 years

Biggest thing to watch: the price has already been rising for 35 weeks, so timing is the risk more than the business. ## What is the MaxLinear share price today? MaxLinear, Inc.'s share price was $63.97 at the close on 3 November 2026. It has been rising for 35 weeks. That is 5.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between $14 and $106, and at that close it sat 55% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 4 weeks running. Over the last 10 years the share price moved +228% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 9 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does MaxLinear pay? MaxLinear, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is MaxLinear on? MaxLinear is on one of our US lists: US tech stocks. [US tech stocks](https://www.sectoralpha.in/us-tech-stocks)

## Is MaxLinear profitable? MaxLinear, Inc. earned $28.9 M of net profit in the Sep 2026 quarter. The full FY25 year was a loss of $137 M. That is 13.3% of the quarter's revenue. The same quarter a year earlier lost $45.5 M. 10 of the last 12 reported quarters were loss-making. ## How much revenue does MaxLinear make, and is it growing? MaxLinear, Inc. reported $218 M of revenue in the Sep 2026 quarter, +72.4% on the same quarter a year earlier. That is the 7th quarter in a row with growth on the year before. Over 4 years it has grown −14.9% a year on average. The last full year, FY25, came in at $468 M. The last four reported quarters add to $661 M. FY25 revenue was $468 M, +29.7% on the year before. Recent pace: the last four quarters grew +54.6% on average, against −14.9% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +56.0%, against +29.5% a year over the last 8 quarters (accelerating). ## How much of every $100 of sales does MaxLinear keep? MaxLinear, Inc.'s operating margin was 14.0% in the Sep 2026 quarter, 37.7 percentage points higher than the same quarter a year ago. Across 5 years it has been between −46.8% and 16.5%. The latest quarter is within that range. Why the margin moved: operating margin changed +37.7 percentage points on the year while gross margin changed +1.8 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is MaxLinear's profit turning into cash? Over the last 2 years, 333% of MaxLinear, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $19.6 M of operating cash against −$137 M of profit. After $12.6 M of spending on assets, $7.0 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does MaxLinear's cash go? MaxLinear, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $43.7 M on assets over the last 3 years. Averaged over those years that is 3.1% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $43.7 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is MaxLinear's P/E ratio, and how does it compare with its own history? MaxLinear, Inc.'s P/E is 22.3×, near the low end of its own history: it has been lower only 20% of the time. Its usual P/E (the middle reading) is 26.6×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the MaxLinear business getting better or worse? MaxLinear, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does MaxLinear earn on its capital? MaxLinear, Inc. earned a ROE of −30% in FY25. That is up from a low of −48% in FY24. Its return on capital used (ROIC) is 26.4 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −29.2% net margin and 0.59× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −29.2% net margin × 0.59× asset turnover × 1.76× leverage (assets divided by equity) ≈ −30.3% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: −0.9% − 25.5% = −26.4 percentage points. The 25.5% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −0.9% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at −19.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does MaxLinear have too much debt? MaxLinear, Inc. has total debt of $186 M against shareholder equity of $533 M as of Sep 2026, so its debt is 0.35× its equity. Year by year, that ratio went from 0.69 in FY21 to 0.32 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the MaxLinear shareholding pattern? 5.2% of MaxLinear, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 1.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is MaxLinear from balance-sheet trouble? For MaxLinear, Inc., the Z-score is 6.54. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 6.54 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does MaxLinear rank in its industry? There is no score against its industry: MaxLinear, Inc. is not among the largest members shown in this industry comparison for Semiconductors. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is MaxLinear compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to MaxLinear in size? MaxLinear is the 33rd largest of 59 Semiconductors companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Silicon Laboratories Inc., Silicon Motion Technology Corporation and Allegro MicroSystems, Inc. Just below it: Impinj, Inc., Cirrus Logic, Inc. and Synaptics Incorporated. ### Semiconductors companies close in size

1. [Silicon Laboratories Inc.](https://www.sectoralpha.in/us/stocks/slab) $7.4 billion
2. [Silicon Motion Technology Corporation](https://www.sectoralpha.in/us/stocks/simo) $6.8 billion
3. [Allegro MicroSystems, Inc.](https://www.sectoralpha.in/us/stocks/algm) $6.3 billion
4. MaxLinear, Inc. $5.8 billion
5. [Impinj, Inc.](https://www.sectoralpha.in/us/stocks/pi) $5.7 billion
6. [Cirrus Logic, Inc.](https://www.sectoralpha.in/us/stocks/crus) $5.6 billion
7. [Synaptics Incorporated](https://www.sectoralpha.in/us/stocks/syna) $4.6 billion

[All 59 Semiconductors companies, largest first](https://www.sectoralpha.in/us/sectors/semiconductors#all-companies)

### Companies close in size in other industries

1. [The Middleby Corporation](https://www.sectoralpha.in/us/stocks/midd) $5.6 billion · Specialty Industrial Machinery
2. [Plexus Corp.](https://www.sectoralpha.in/us/stocks/plxs) $5.6 billion · Electronic Components
3. MaxLinear, Inc. $5.6 billion
4. [Mirum Pharmaceuticals, Inc.](https://www.sectoralpha.in/us/stocks/mirm) $5.6 billion · Biotechnology
5. [Fortune Brands Innovations, Inc.](https://www.sectoralpha.in/us/stocks/fbin) $5.6 billion · Building Products & Equipment

## What else do people ask about MaxLinear? ### What were MaxLinear's latest quarterly results? MaxLinear, Inc. reported revenue of $218 M and net profit of $28.9 M for the Sep 2026 quarter. Earnings per share were $0.30. The operating margin was 14.0%, 37.7 percentage points higher than a year earlier (as of 3 November 2026). ### What is MaxLinear's market cap? MaxLinear, Inc.'s market capitalisation is $5.8 B at a stock price of $63.97. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is MaxLinear performing? MaxLinear, Inc.'s share price has been rising for 35 weeks. Over the past 13 weeks it has done worse than the S&P 500, for 4 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will MaxLinear's stock price go up? This page does not forecast MaxLinear, Inc.'s stock price. What it shows instead: the stock price is $63.97, and it has been rising for 35 weeks. Its P/E of 22.3× is higher than 20% of its own last 2 years (as of 3 November 2026). ### Is MaxLinear's profit real cash? Yes, over the last 2 years, 333% of MaxLinear, Inc.'s reported profit came in as cash from operations. The latest year was lower at -14%, so the trend is worth watching. In FY25, operating cash was $19.6 M against reported profit of −$137 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is MaxLinear in its business cycle? MaxLinear, Inc.'s FY25 operating margin was −21.9%, against a 5-year range of −46.8% to 16.5%: the middle of its own range, neither a peak nor a low. The latest quarter was 14.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the MaxLinear story? Biggest thing to watch: the price has already been rising for 35 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is MaxLinear a stock worth studying right now? What the numbers show: MaxLinear, Inc.'s results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 20% of past readings. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- US tech stocks: https://www.sectoralpha.in/us-tech-stocks

This is research, not advice. We’re not SEBI-registered.